HCW Biologics Inc. - Common Stock (HCWB)
4.0254
-0.0346 (-0.85%)
NASDAQ · Last Trade: Jul 7th, 3:05 PM EDT
Ewan Laskey, born in New York City in 1978, is a fintech entrepreneur, investment expert, and philanthropist with a global perspective and a spirit of innovation.
Via Binary News Network · July 7, 2025

Investors are turning their attention to a lineup of Nasdaq-listed companies making waves in their respective industries.
Via AB Newswire · November 18, 2024

Showed HCW9218 clinical safety and tumor response endpointsfor 15 patients with heavily pretreated advanced solid tumors
By HCW Biologics, Inc · Via GlobeNewswire · November 8, 2023

HCW9218 is the lead product candidate of HCW Biologics Inc.
By HCW Biologics, Inc · Via GlobeNewswire · November 1, 2023

Company will provide an update for clinical development and intellectual property programs, Including recent achievements and expected milestones in the next 12 months
By HCW Biologics, Inc · Via GlobeNewswire · September 6, 2023

Provides funding for buildout of new headquarters and manufacturing facility
By HCW Biologics, Inc · Via GlobeNewswire · April 27, 2023

NCI Activated as Clinical Site for Phase 1b/2 Clinical Trial to Evaluate HCW9218 in Advanced Pancreatic Cancer
By HCW Biologics, Inc · Via GlobeNewswire · December 8, 2022